IDH1 and glioma: The absence of the IDH1 mutation and the relatively high prevalence of the H3F3A mutation (21.4%) in pediatric high-grade glioma has also been confirmed in the work of Jha et al. Moreover, the authors noted the association of the H3F3A mutation with changes in miRNA levels among those patients.